Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-13-041518
Filing Date
2013-08-20
Accepted
2013-08-20 15:13:57
Documents
1
Period of Report
2012-12-21

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c588466_4ax0.html 4/A  
1 MAIN DOCUMENT DESCRIPTION c588466_4ax0.xml 4/A 4855
  Complete submission text file 0001209191-13-041518.txt   6377
Mailing Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL SUITE 101 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARSHALL EDWARDS, INC. 11975 EL CAMINO REAL, SUITE 101 SAN DIEGO CA 92130
Business Address
Baltic Charles V. III (Reporting) CIK: 0001533340 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50484 | Film No.: 131050657